ResearchMoz

Coronary Stents Market in India 2013

Netscribes (India) Pvt. Ltd.
Published Date » 2013-10-31
No. Of Pages » 134
   
 Netscribes’ latest market research report titled Coronary stents Market in India 2013 states that manufacturers of coronary stents are experiencing high demand for their products due to a number of factors. Since cardiovascular diseases have become a common occurrence among the Indian population and the healthcare infrastructure in the country is rapidly improving, it has built a strong case for angioplasty procedures in the country. Moreover, an increase in awareness and the willingness to spend on healthcare is benefiting the market. Also, advancements in technology such as the introduction of bioabsorbable stents in the Indian market in December 2012 has made such stents more acceptable to patients, thereby providing further stimulus for market growth. With growth in the...
Table of Content

Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2009-10, 2010-11, 2011-12, 2012-13), Inflation Rate: Monthly (Nov 2012 – Apr 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Sep 2011-Feb 2012), Exchange Rate: Monthly (Dec 2012 – May 2013)
Slide 4: Lending Rate: Annual (2009-10, 2010-11, 2011-12, 2012-13), Trade Balance: Annual, FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Introduction
Slide 5: Coronary stents – Uses, Characteristics and Types
Slide 6: Development of Coronary Stents

Market Overview
Slide 7: Angioplasties – Overview and Number of Procedures Performed in India (2009 – 2017e)
Slide 8: Coronary Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011 – 2017e)
Slide 9: Drug-Eluting Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011 – 2017e)
Slide 10: Bare Metal Stents – Market Overview, Market Size & Growth (Value-Wise; 2011 – 2017e & Volume-Wise; 2011 – 2017e)
Slide 11: Bioabsorbable Stents – Market Overview, Market Size & Growth (Value-Wise; 2013e – 2017e & Volume-Wise; 2013e – 2017e)
Slide 12: Coronary Stents – Price Trends

Drivers & Challenges
Slide 13: Drivers and Challenges – Summary
Slide 14-18: Drivers
Slide 19-20: Challenges

Government Involvement
Slide 21: Organizational Structure of Regulatory Bodies
Slide 22-23: Regulatory Bodies
Slide 24-27: Regulatory Policies
Slide 28: Process of Obtaining License for Manufacturing Medical Device Regulated as Drugs in India
Slide 29-31: Requirements for Grant of License for Manufacture of Medical Devices in India
Slide 32: Process of Obtaining Registration for Import of Medical Device Regulated as Drugs in India
Slide 33-37: Documents Required for the Registering Medical Devices for Import into India

Competitive Landscape
Slide 38-40: Entry Barriers
Slide 41: Porter’s Five Forces Analysis
Slide 42: Competition Overview, Market Share of Companies (Volume-Wise; 2012)
Slide 43: Sale of Coronary Stents by Various Companies (2012)
Slide 44-47: Competitive Benchmarking 
Slide 48-96: Major Companies

Buyer Details
Slide 97: List of Top 10 Hospitals Buying Coronary Stents in India
Slide 98-127: Major Buyers
Slide 128: Other Major Purchasers of Stents

Recent Developments
Slide 129: Major Recent Developments in the Market

Strategic Recommendation
Slide 130-131: Key Recommendations
Slide 132: Opportunities by Geography

Appendix
Slide 133: Appendix
Slide 134: Sources of Information

List of Tables


Market Overview
1. Coronary Stents – Price Trends

Government Involvement
1. Reimbursement Rates Under Central Government Health Scheme (2007, 2011, 2013)

Competitive Landscape
1. Company Profiles (All Companies)
a. Company Information (All Companies)
b. Products and Services (All Companies)
c. Key People (All Companies)
d. Shareholders of the Company (Private Companies, Except B. Braun Medical (India) Pvt. Ltd. & MIV Therapeutics (India) Pvt. Ltd.)
a. Key Financial Performance Indicators (Public Companies)
b. Key Ratios (Except Boston Scientific India Pvt. Ltd.)
e. Business Highlights (All Companies)

Buyer Details
1. Top 10 Hospitals Buying Coronary Stents In India
2. Buyer Profiles (All Companies)
c. Company Information (All Companies)
d. Products and Services (All Companies)
e. Key People (All Companies)
f. Business Highlights (All Companies)
g. Key Hospital Indicators
f. Stent Procurement Procedure

Appendix
2. Appendix
3. Sources of Information

List of Figures


Macro Economic Indicators
1. GDP at Factor Cost: Quarterly (2009-10, 2010-11, 2011-12, 2012-13)
2. Inflation Rate: Monthly (Nov-Dec 2012 – Mar-Apr 2013)
3. Gross Fiscal Deficit: Monthly (Sep 2011 - Feb 2012)
4. Exchange Rate: Monthly (Dec 2012 – May 2013)
5. Lending Rate: Annual (2009-10, 2010-11, 2011-12, 2012-13)
6. Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13)
7. FDI Annual (2009-10, 2010-11, 2011-12, 2012-13)

Market Overview
1. Number of Angioplasty Procedures (2009 – 2017e)
2. Coronary Stents – Market Size & Growth (Value-Wise; 2011 – 2017e)
3. Coronary Stents – Market Size & Growth (Volume-Wise; 2011 – 2017e)
4. Drug-Eluting Stents – Market Size & Growth (Value-Wise; 2011 – 2017e)
5. Drug-Eluting Stents – Market Size & Growth (Volume-Wise; 2011 – 2017e)
6. Bare Metal Stents – Market Size & Growth (Value-Wise; 2011 – 2017e)
7. Bare Metal Stents – Market Size & Growth (Volume-Wise; 2011 – 2017e)
8. Bioabsorbable Stents – Market Size & Growth (Value-Wise; 2013e – 2017e)
9. Bioabsorbable Stents – Market Size & Growth (Volume-Wise; 2013e – 2017e)

Drivers & Challenges
1. CVD Prevalence – Number of Patients (2011 – 2017e)
2. Diabetes Prevalence – Number of Patients (2011 – 2017e)
3. Budget Allocation of Funds for Healthcare Sector (2010-11 – 2013-14)
4. Private Hospitals Market in India (Value-Wise; 2011 – 2017e)
5. Population Above 60 Years (2011 – 2017e)
6. Average Life Expectancy (1960, 1970, 1980, 1990, 2000, 2011)
7. Household Expenditure – Share of Wallet % (2005, 2015e, 2025e)

Competitive Landscape
1. Market Share (Volume-Wise; 2012)
2. Competitive Benchmarking – Key Ratios of 4 Major Companies – Operational & Financial Basis (2011-2012)
3. Company profiles (All Companies)
a. Ownership Structure (Private Companies)
b. Financial Snapshot (Except Boston Scientific India Pvt. Ltd.) 
c. Key Business segments (Public Companies)
d. Key Geographic segments (Public Companies)

Upcoming Reports:

Poland: market of stainless steel sinks and wash basins
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the stainless steel sinks and wash basins market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the stainless steel sinks and wash basins market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same...
Medical Plastics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Increasing need for medical devices with high shelf life, increasing export and import of medical devices, increasing demand for sterilized and disposable devices are some of the factors driving the sales of medical plastics market. Increasing demand for cost effective, light weight, the increasing use of prosthetics and the increasing use of non magnetic equipments around heavily magnetized medical equipments such as an MRI, are other factors serving as market drivers for the medical plastics market.  The rising economies in the Asia Pacific region, the rising demand for high...
3D Scanning Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
3D scanner analyzes a real-world environment or object and collects data on its figure and conceivably its appearance (i.e. color). The composed data is used to develop digital three-dimensional models. 3D scanning is classified under two categories, namely, non-contact 3D scanning and contact 3D scanning. Coordinate measuring machine (CMM) is an example of 3D contact scanner. Time of flight and Triangulation techniques are included in the 3D non- contact scanning. The 3D scanning can be categorized on the basis of devices, applications and services, verticals and geography. These...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...